July 18, 2012 -- Techsol Corporation, a pioneer in offering technology services for the pharmaceutical and life sciences industry, announced the release of QuickLaunch, an accelerated ‘Oracle health sciences LabPas ’ deployment package which enables pharmaceutical, contract research organisations (CRO’s) and academic medical research institutions to swiftly automate their current early phase clinical units in compliance to the FDA’s regulatory requirements of 21 CFR part 11 and go-live within a very short time span.
As part of the QuickLaunch package, the company has also re-engineered a flexible early phase clinical trials process management framework to augment the automation capabilities of LabPas in order to make clinical unit operations more lean and efficient thereby reducing effort, time, and money for clinical research organisations conducting early phase clinical trials.
“We designed this package along with its deployment framework based on our industry insight and understanding of challenges faced by companies while setting up a regulatory compliant automated early phase clinical unit. QuickLaunch is a cost-effective, ready-to-use, pre-configured and validated package of the Oracle health sciences LabPas solution. Overall our package is very comprehensive and LabPas is a brilliant enterprise solution which can enable the automation of early phase clinical units within a small time frame in a seamless manner,” informed Subbaraju Sagi, CEO & managing director of Techsol Corporation.
Some of the salient features of the LabPas QuickLaunch package is that it offers ready-to-use pre-configured, pre-validated LabPas virtual servers built based on early phase industry best practices and regulatory compliance requirements. It also reduces deployment time and operational risks resulting in cost savings and faster business user adoption and offers customer choices for implementation with high availability architecture to meet the SLAs of customers.
It includes consulting services to deploy the virtual servers, validation services, training, data migration etc. and is supported by 24x7 LabPas Service Desk (LSD) which handles incidents, requests and change management needs after the Go-LIVE.
LabPas QuickLaunch package offers a custom reporting framework to support additional reporting needs and is available with various optional add-ons like pre-installed hardware along with OS, scanners, printers, instruments, hand held devices etc. and available for on-site as well as for hosted deployment.
About Oracle Health Sciences LabPas TM
Oracle Health Sciences LabPas helps meet the demands of today’s early phase clinical units by providing capabilities for volunteer enrollment, screening and recruitment management, Direct clinical trial data capture, Automated sample processing, Data Qualification and flexible reporting capabilities. LabPas can help to reduce errors and queries, allowing clinics to operate more efficiently while meeting critical timelines and improving overall data quality.
About Techsol Corporation
Techsol Corporation is a global technology service provider for pharmaceutical companies, Life Sciences and Contract Research Organizations (CROs). The company is affiliated to oracle as a Gold Partner through the Oracle® Partner Network (OPN) and specializes in offering end-to-end consulting services in requirement analysis, solution designing, implementation, validation, training, upgrade, data migration and other value added services around Oracle Health Sciences Solutions in the verticals of Clinical Data Management (LabPas, Oracle Clinical, RDC, TMS), Pharmacovigilance / Safety Reporting (Oracle Argus Safety Suite, AERS), Signal Detection and Management (Empirica Signal and Study) and Clinical Trial Management (Siebel Clinical). Trademarks: Techsol acknowledges that Oracle is a registered trademark of Oracle Corporation and/or its affiliates.
For QuickLaunch enquiries, please contact:
North America: Mr. Rahul Bhangay, Sales Director
Phone: +1 415 723 3371 APAC
Europe: Mr. Fahd Khan, Sales Associate Director
Phone: +91 8886035847
For partnership enquiries, please contact:
Mr. Subbaraju Sagi, CEO&MD
twitter.com/TechsolCorp Facebook: facebook.com/TechsolCorporation